HGH Fragment 176-191 5 mg (5000 mcg)/vial – US Stock

HGH Fragment 176-191 5 mg (5000 mcg)/vial from Hilma Biocare is a peptide formulation containing HGH Fragment 176-191, a segment derived from the human growth hormone molecule. The product is supplied as an injectable powder in a single vial containing 5 mg (5000 mcg).

Product Overview

HGH Fragment 176-191 represents a specific portion of the larger human growth hormone molecule. The supplied product description associates this peptide fragment with lipolysis and metabolic processes and distinguishes it from full-length human growth hormone.

The product specifications identify an active half-life of approximately 20–30 hours. The formulation is classified as a peptide hormone in injectable powder form and is specified as having no water retention or aromatization.

Active Ingredient

The stated active ingredient is HGH Fragment 176-191.

Form and Strength

The product is supplied as an injectable powder containing 5 mg (5000 mcg) per vial.

Product Characteristics

According to the supplied specifications, HGH Fragment 176-191 has the following characteristics:

• Peptide hormone formulation
• HGH-derived peptide fragment
• Injectable powder presentation
• 5 mg (5000 mcg) per vial
• Approximately 20–30-hour active half-life
• Single-vial pack
• No water retention listed
• No aromatization listed

Product Specifications

Product Characteristics

HGH Fragment 176-191 is a peptide fragment derived from the human growth hormone molecule. The supplied description focuses on its association with fat metabolism and lipolysis rather than the broader physiological activity of full-length HGH.

The source material also describes the peptide in relation to metabolism, energy, skeletal health, and general well-being. These descriptions reflect the supplied product information and should not be interpreted as guaranteed fat-loss, anti-aging, performance, or health outcomes.

Reported Side Effects

The supplied product information identifies the following possible adverse reactions:

• Soreness or itching at the injection site
• Insomnia

Individual responses may vary. Because this is a biologically active peptide intended for injectable use, potential risks, contraindications, and interactions should be evaluated with an appropriately qualified healthcare professional.

Important Information

HGH Fragment 176-191 is a biologically active peptide and is not presented as a general nutritional supplement. The information on this page is provided for product identification and factual specification purposes only and does not constitute personalized medical advice.

No dosage recommendations, injection instructions, reconstitution procedures, treatment protocols, or stacking regimens are provided. The supplied source mentions combining this peptide with other peptides, anabolic-androgenic steroids, or full-length HGH; these combinations are not presented here as recommendations.

About Hilma Biocare USA

HGH Fragment 176-191 5 mg (5000 mcg)/vial is part of the Hilma Biocare product range. The product contains a labeled 5 mg (5000 mcg) quantity of HGH Fragment 176-191 and is supplied as one injectable powder vial, listed as US Stock.